GO:0001735 prenylcysteine oxidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001735 prenylcysteine oxidase activity catalyzes the oxidative cleavage of S-prenyl-L-cysteine to a prenal, L-cysteine, and hydrogen peroxide.
• The reaction is carried out by prenylcysteine oxidases, including PCYOX1 and PCYOX1L, which are flavin-dependent enzymes with a conserved vanin-like fold.
• PCYOX1 is a secreted pro-oxidant enzyme that associates with low-density lipoproteins and high-density lipoproteins and contributes to oxidative stress in the vascular compartment.
• PCYOX1 regulates adipogenesis and thrombosis, while PCYOX1L is required for neutrophil bactericidal activity and controls the surface expression of acid-sensing ion channel 1a.
• Dysregulated prenylcysteine oxidase activity has been linked to metabolic, cardiovascular, and neurodegenerative conditions, including Alzheimer's disease and type 2 diabetes mellitus.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise dissection of PCYOX1 and PCYOX1L functions in health and disease.
Description
Prenylcysteine oxidase activity (GO:0001735) is a molecular function that removes prenyl groups from S-prenylated cysteine residues through an oxidative reaction. The enzyme uses molecular oxygen and water to convert S-prenyl-L-cysteine into a prenal, L-cysteine, and hydrogen peroxide, thereby participating in the turnover of prenylated proteins and the generation of reactive oxygen species. This activity is conserved across mammals and is represented by two main enzymes in humans: prenylcysteine oxidase 1 (PCYOX1) and prenylcysteine oxidase 1 like (PCYOX1L). Because prenylation is a common post-translational modification that anchors proteins to membranes, the oxidative cleavage of prenylcysteines has broad implications for protein trafficking, signaling, and cellular redox balance. Researchers study GO:0001735 to understand how cells dispose of prenylated proteins and how this process contributes to oxidative stress, metabolic regulation, and immune defense. The reaction product hydrogen peroxide is itself a signaling molecule, linking prenylcysteine oxidase activity to redox-sensitive pathways and to the pathogenesis of diseases such as atherosclerosis, thrombosis, and neurodegeneration.
prenylcysteine oxidase activity At A Glance
| GO ID | GO:0001735 |
|---|---|
| GO term | prenylcysteine oxidase activity |
| Ontology | molecular_function |
| Synonym | prenylcysteine lyase activity; S-prenyl-L-cysteine:oxygen oxidoreductase activity |
| Major function | Oxidative cleavage of S-prenyl-L-cysteine to a prenal, L-cysteine, and H2O2 |
| Representative enzymes | PCYOX1, PCYOX1L |
| Cofactor | Flavin adenine dinucleotide (FAD) |
| Subcellular localization | Secreted; associated with lipoproteins |
| Reaction products | Prenal, L-cysteine, hydrogen peroxide |
What Is GO:0001735?
Prenylcysteine oxidase activity (GO:0001735) is defined as the catalysis of the reaction: S-prenyl-L-cysteine + O2 + H2O = a prenal + L-cysteine + H2O2. In other words, the enzyme cleaves the thioether bond of a prenylated cysteine residue, releasing a prenaldehyde, free cysteine, and hydrogen peroxide. This activity is synonymous with prenylcysteine lyase activity and S-prenyl-L-cysteine:oxygen oxidoreductase activity.
Why Is prenylcysteine oxidase activity Important in Cell Biology?
Prenylcysteine oxidase activity is important because it controls the catabolism of prenylated proteins and generates hydrogen peroxide, a reactive oxygen species that can modify lipids, proteins, and DNA. This dual role places the enzyme at the intersection of protein turnover and redox signaling. Dysregulation of PCYOX1, one of the enzymes carrying this activity, has been implicated in atherosclerosis, thrombosis, and adipogenesis, while PCYOX1L is essential for neutrophil bactericidal function and for the surface expression of acid-sensing ion channel 1a. Understanding GO:0001735 therefore provides insight into cardiovascular disease, metabolic disorders, innate immunity, and neurodegeneration.
• Regulates the degradation of prenylated proteins, influencing membrane association and signaling of small GTPases.
• Generates hydrogen peroxide, contributing to oxidative stress and redox signaling in the vascular wall.
• PCYOX1 is a pro-oxidant enzyme of low-density lipoproteins and a marker of high-density lipoprotein function after stroke.
• PCYOX1 modulates adipogenesis, linking prenylcysteine oxidation to obesity and metabolic syndrome.
• PCYOX1 is a new player in thrombosis, affecting platelet function and clot formation.
• PCYOX1L is required for neutrophil bactericidal activities, connecting the enzyme to innate immunity.
• PCYOX1L controls the surface expression of acid-sensing ion channel 1a, with implications for pain and acidosis sensing.
• Altered prenylcysteine oxidase activity has been associated with Alzheimer's disease and type 2 diabetes mellitus in meta-analyses.
• The enzyme is a potential therapeutic target for cardiovascular and metabolic diseases.
• CRISPR models of PCYOX1 and PCYOX1L enable causal testing of these associations.
Molecular Mechanism of prenylcysteine oxidase activity
Substrate recognition and binding
In simple terms: The enzyme grabs a prenylated cysteine and holds it in place.
Prenylcysteine oxidases recognize the prenyl moiety of S-prenyl-L-cysteine, a modification typically found at the C-terminus of proteins such as Ras and Rho GTPases. The enzyme binds the substrate through a hydrophobic pocket that accommodates the prenyl chain, positioning the thioether bond for cleavage.
Oxidative cleavage of the thioether bond
In simple terms: Oxygen and water break the bond between the prenyl group and cysteine.
The catalytic mechanism involves the oxidation of the thioether bond by molecular oxygen, resulting in the release of a prenaldehyde, free L-cysteine, and hydrogen peroxide. This reaction is flavin-dependent, with FAD acting as a cofactor to shuttle electrons from the substrate to oxygen.
Flavin cofactor and electron transfer
In simple terms: A vitamin B2-derived helper molecule passes electrons to oxygen.
The enzyme contains a non-covalently bound FAD that is reduced by the substrate and re-oxidized by oxygen, producing hydrogen peroxide. The conserved vanin-like fold of mammalian prenylcysteine oxidases supports this electron transfer chain.
Product release and cellular fate
In simple terms: The products are released and can act as signals or waste.
After cleavage, the prenaldehyde and cysteine are released, and hydrogen peroxide diffuses into the cellular environment. The prenaldehyde can be further metabolized, while hydrogen peroxide contributes to redox signaling or oxidative damage.
Regulation by localization and secretion
In simple terms: The enzyme is secreted and can act on lipoproteins in the blood.
PCYOX1 is a secreted enzyme that associates with low-density and high-density lipoproteins, where it can oxidize prenylated substrates and generate hydrogen peroxide in the vascular compartment. This localization links prenylcysteine oxidase activity to lipoprotein oxidation and cardiovascular risk.
Key Genes Involved in GO:0001735 prenylcysteine oxidase activity
The following genes and proteins are directly associated with prenylcysteine oxidase activity (GO:0001735) or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCYOX1 | Prenylcysteine oxidase 1; catalyzes oxidative cleavage of S-prenyl-L-cysteine | Pro-oxidant enzyme of LDL; regulates adipogenesis and thrombosis |
| PCYOX1L | Prenylcysteine oxidase 1 like; catalyzes the same reaction | Required for neutrophil bactericidal activity; controls ASIC1a surface expression |
| VNN1 | Vanin-1; related pantetheinase with similar fold | Model for the vanin-like fold of prenylcysteine oxidases |
| VNN2 | Vanin-2; related pantetheinase | Comparative studies of enzyme evolution |
| VNN3 | Vanin-3; related pantetheinase | Comparative studies of enzyme evolution |
| RAS | Small GTPase; prenylated substrate | Prenylation-dependent membrane targeting |
| RHOA | Small GTPase; prenylated substrate | Prenylation-dependent signaling |
| RAC1 | Small GTPase; prenylated substrate | Prenylation-dependent signaling |
| CDC42 | Small GTPase; prenylated substrate | Prenylation-dependent signaling |
| ASIC1 | Acid-sensing ion channel 1a; surface expression controlled by PCYOX1L | Pain and acidosis sensing |
| APOE | Apolipoprotein E; lipid transport | Link to Alzheimer's disease and type 2 diabetes |
| INS | Insulin; metabolic regulation | Link to type 2 diabetes mellitus |
| APP | Amyloid precursor protein | Link to Alzheimer's disease |
| TNF | Tumor necrosis factor; inflammation | Link to metabolic and cardiovascular disease |
| IL6 | Interleukin 6; inflammation | Link to metabolic and cardiovascular disease |
| PPARG | Peroxisome proliferator-activated receptor gamma; adipogenesis | PCYOX1 regulates adipogenesis |
| F2 | Prothrombin; coagulation | PCYOX1 is a new player in thrombosis |
| FGA | Fibrinogen alpha chain; coagulation | PCYOX1 is a new player in thrombosis |
How Is prenylcysteine oxidase activity Regulated?
Prenylcysteine oxidase activity is regulated at multiple levels. PCYOX1 is a secreted enzyme, and its localization to lipoproteins influences substrate access and product generation in the vascular compartment. The expression of PCYOX1 is modulated during adipogenesis, suggesting transcriptional control by adipogenic transcription factors such as PPARG. In neutrophils, PCYOX1L is required for bactericidal activity, and its function may be regulated by inflammatory signals. The enzyme's product hydrogen peroxide can feedback on redox-sensitive pathways, indirectly affecting its own expression and activity. Additionally, the conserved vanin-like fold and FAD cofactor dependence provide a structural basis for regulation by cofactor availability and redox state.
prenylcysteine oxidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCYOX1 | Atherosclerosis, thrombosis, adipogenesis | ApoE-/- or LDLR-/- mouse models with PCYOX1 KO |
| PCYOX1L | Neutrophil bactericidal activity, infection | Pcyox1l KO mouse or neutrophil-specific KO |
| PCYOX1L | Acid-sensing ion channel 1a surface expression | ASIC1a knock-in reporter cells |
| PCYOX1 | Alzheimer's disease and type 2 diabetes mellitus | APP/PS1 or db/db mice with PCYOX1 modulation |
| PCYOX1 | Stroke recovery and HDL function | Middle cerebral artery occlusion model |
Cardiovascular disease and thrombosis
PCYOX1 is a pro-oxidant enzyme of low-density lipoproteins and is carried by high-density lipoproteins as a marker that tracks with recovery from stroke. It has been identified as a new player in thrombosis, influencing platelet function and clot formation. These findings suggest that prenylcysteine oxidase activity contributes to oxidative stress and thrombotic risk in cardiovascular disease.
Metabolic disorders and adipogenesis
PCYOX1 is a key regulator of adipogenesis, and its expression changes during adipocyte differentiation. Meta-analyses have linked genomic and transcriptomic signatures of Alzheimer's disease with type 2 diabetes mellitus, implicating prenylcysteine oxidase activity in metabolic and neurodegenerative crosstalk. Dysregulated prenylcysteine oxidation may therefore contribute to obesity, insulin resistance, and related metabolic syndromes.
Innate immunity and infection
PCYOX1L is required for neutrophil bactericidal activities, and its loss impairs the ability of neutrophils to kill bacteria. This places prenylcysteine oxidase activity in the front line of innate immune defense. Additionally, PCYOX1L controls the surface expression of acid-sensing ion channel 1a, which is involved in pain and acidosis sensing.
Neurodegeneration
The link between Alzheimer's disease and type 2 diabetes mellitus identified by meta-analysis includes prenylcysteine oxidase activity as part of shared molecular pathways. Oxidative stress generated by PCYOX1 may contribute to neuronal damage, although direct evidence for PCYOX1 in neurodegeneration requires further study.
From prenylcysteine oxidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PCYOX1 loss reduce oxidative stress in atherosclerosis? | PCYOX1 knockout in ApoE-/- mice |
| Does PCYOX1L deficiency impair neutrophil killing? | PCYOX1L knockout in neutrophil cell lines or mice |
| How does PCYOX1 point mutation affect catalytic activity? | CRISPR point mutation of catalytic residues in PCYOX1 |
| Does PCYOX1L control ASIC1a surface expression? | PCYOX1L knockout with ASIC1a knock-in reporter |
| Can PCYOX1 overexpression induce adipogenesis? | PCYOX1 overexpression in preadipocytes |
| Does PCYOX1 secretion affect thrombosis? | Tagged knock-in of PCYOX1 in platelets |
How to Study the prenylcysteine oxidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | Hydrogen peroxide or prenaldehyde production | Confirm PCYOX1/PCYOX1L catalytic activity |
| Mass spectrometry proteomics | PCYOX1 abundance in lipoproteins | Clinical biomarker discovery |
| CRISPR knockout screening | Gene essentiality and pathway interactions | Identify regulators of adipogenesis and immunity |
| Western blot | Protein expression and secretion | Validate knockout or overexpression |
| Immunofluorescence | Subcellular localization | Track PCYOX1L and ASIC1a trafficking |
| RNA-seq | Transcriptional changes | Assess PCYOX1-dependent gene expression |
| Lipoprotein oxidation assay | LDL oxidation status | Measure pro-oxidant effects of PCYOX1 |
| Neutrophil killing assay | Bactericidal activity | Test PCYOX1L requirement in immunity |
Enzymatic activity assays
Prenylcysteine oxidase activity can be measured using synthetic S-prenyl-L-cysteine substrates and monitoring the production of hydrogen peroxide or prenaldehyde by fluorescence or mass spectrometry. These assays are used to confirm the catalytic function of PCYOX1 and PCYOX1L and to test the effects of mutations.
Proteomics and lipoprotein profiling
Proteomic analyses of lipoprotein fractions have identified PCYOX1 as a component of LDL and HDL, and have linked its abundance to stroke recovery. Mass spectrometry-based proteomics can quantify PCYOX1 in clinical samples and model systems.
CRISPR screening and functional genomics
CRISPR knockout screens can identify genes that modulate prenylcysteine oxidase activity or its downstream effects. Such screens have been used to study adipogenesis and neutrophil function, where PCYOX1 and PCYOX1L play key roles.
Imaging and subcellular localization
Fluorescence microscopy of tagged PCYOX1 or PCYOX1L can reveal their secretion and association with lipoproteins or the cell surface. Imaging of ASIC1a surface expression in PCYOX1L knockout cells demonstrates the role of the enzyme in trafficking.
How CRISPR Can Be Used to Study GO:0001735 prenylcysteine oxidase activity
Knockout
CRISPR knockout of PCYOX1 or PCYOX1L eliminates prenylcysteine oxidase activity, enabling loss-of-function studies in adipogenesis, thrombosis, and neutrophil bactericidal activity. Knockout models can also reveal compensatory mechanisms and substrate accumulation.
Point Mutation
Point mutations in the catalytic residues of PCYOX1 or PCYOX1L can dissect the enzymatic mechanism and separate catalytic activity from non-catalytic functions. Such mutations are guided by the conserved vanin-like fold and FAD-binding motifs.
Knock-in
Knock-in of tagged PCYOX1 or PCYOX1L allows tracking of secretion, lipoprotein association, and subcellular localization. Knock-in of disease-associated variants can model human genetic risk.
Overexpression
Overexpression of PCYOX1 or PCYOX1L increases hydrogen peroxide production and can induce oxidative stress, adipogenesis, or altered ion channel trafficking. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports prenylcysteine oxidase activity Research
Researchers studying prenylcysteine oxidase activity-related genes often need to determine whether a candidate gene is causally involved in oxidative stress, metabolic regulation, or immune defense. EDITGENE provides CRISPR-based tools to create precise knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics services, to accelerate functional validation of PCYOX1, PCYOX1L, and their pathways.
Contact EDITGENE today to design your custom CRISPR model for prenylcysteine oxidase activity research.
Frequently Asked Questions About prenylcysteine oxidase activity
What is prenylcysteine oxidase activity?
Prenylcysteine oxidase activity (GO:0001735) is the catalysis of the reaction S-prenyl-L-cysteine + O2 + H2O = a prenal + L-cysteine + H2O2, removing prenyl groups from cysteine residues.
What genes are involved in prenylcysteine oxidase activity?
The main genes are PCYOX1 and PCYOX1L, which encode prenylcysteine oxidase 1 and prenylcysteine oxidase 1 like, respectively.
What is the function of PCYOX1?
PCYOX1 is a secreted pro-oxidant enzyme that oxidizes prenylcysteines, associates with lipoproteins, and regulates adipogenesis and thrombosis.
What is the function of PCYOX1L?
PCYOX1L catalyzes the same reaction and is required for neutrophil bactericidal activity and for the surface expression of acid-sensing ion channel 1a.
How is prenylcysteine oxidase activity measured?
It is measured by enzymatic assays that detect hydrogen peroxide or prenaldehyde production from S-prenyl-L-cysteine substrates.
What diseases are associated with prenylcysteine oxidase activity?
It has been linked to atherosclerosis, thrombosis, metabolic disorders, Alzheimer's disease, type 2 diabetes mellitus, and impaired innate immunity.
Is prenylcysteine oxidase activity involved in oxidative stress?
Yes, the reaction produces hydrogen peroxide, which contributes to oxidative stress and redox signaling in the vascular compartment.
What is the reaction catalyzed by prenylcysteine oxidase?
The enzyme converts S-prenyl-L-cysteine, oxygen, and water into a prenal, L-cysteine, and hydrogen peroxide.
Can CRISPR be used to study prenylcysteine oxidase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of PCYOX1 and PCYOX1L.
What is the clinical significance of PCYOX1 in stroke?
PCYOX1 is carried by high-density lipoprotein and its levels track with recovery from stroke, suggesting a role in vascular repair.
Conclusion
Prenylcysteine oxidase activity (GO:0001735) is a conserved enzymatic function that cleaves prenylated cysteines to generate hydrogen peroxide, influencing protein turnover, redox signaling, and cellular metabolism. The two main enzymes, PCYOX1 and PCYOX1L, have been implicated in cardiovascular disease, thrombosis, adipogenesis, innate immunity, and neurodegeneration. Continued research using CRISPR models and multi-omics approaches will clarify how this activity can be targeted for therapeutic benefit. EDITGENE provides comprehensive CRISPR services to support these investigations.
References
- 1. Herrera-Marcos LV et al.. 2018. Prenylcysteine oxidase 1, a pro-oxidant enzyme of low density lipoproteins.. Front Biosci (Landmark Ed) 23(6):1020-1037 PMID: 28930587
- 2. Barone M et al.. 2024. Evolution, structure, and drug-metabolizing activity of mammalian prenylcysteine oxidases.. J Biol Chem 300(11):107810 PMID: 39322016
- 3. Banfi C et al.. 2023. Prenylcysteine Oxidase 1 Is a Key Regulator of Adipogenesis.. Antioxidants (Basel) 12(3) PMID: 36978789
- 4. Banfi C et al.. 2022. Prenylcysteine Oxidase 1 (PCYOX1), a New Player in Thrombosis.. Int J Mol Sci 23(5) PMID: 35269975
- 5. Petenkova A et al.. 2023. Prenylcysteine oxidase 1 like protein is required for neutrophil bactericidal activities.. Nat Commun 14(1):2761 PMID: 37179332
- 6. Kuspiel S et al.. 2025. The secreted protein PCYOX1L controls the surface expression of acid-sensing ion channel 1a.. Sci Adv 11(30):eadw4064 PMID: 40712023
- 7. Mirza Z et al.. 2014. Establishing genomic/transcriptomic links between Alzheimer's disease and type 2 diabetes mellitus by meta-analysis approach.. CNS Neurol Disord Drug Targets 13(3):501-16 PMID: 24059308
- 8. Plubell DL et al.. 2020. High-Density Lipoprotein Carries Markers That Track With Recovery From Stroke.. Circ Res 127(10):1274-1287 PMID: 32844720
